Rottey S - Search Results

1

Pembrolizumab for the treatment of bladder cancer.

Sundahl N, Rottey S, De Maeseneer D, Ost P. Sundahl N, et al. Among authors: rottey s. Expert Rev Anticancer Ther. 2018 Feb;18(2):107-114. doi: 10.1080/14737140.2018.1421461. Epub 2017 Dec 29. Expert Rev Anticancer Ther. 2018. PMID: 29284318 Review.

2

F-18 fluorodeoxyglucose PET/CT scanning in the diagnostic work-up of a primary pericardial mesothelioma: a case report.

Ost P, Rottey S, Smeets P, Boterberg T, Stragier B, Goethals I. Ost P, et al. Among authors: rottey s. J Thorac Imaging. 2008 Feb;23(1):35-8. doi: 10.1097/RTI.0b013e318156eb39. J Thorac Imaging. 2008. PMID: 18347518

3

Targeted therapy for metastatic renal cell cancer.

Verbaeys C, Hoebeke P, Van Belle S, Rottey S. Verbaeys C, et al. Among authors: rottey s. Acta Clin Belg. 2010 Mar-Apr;65(2):115-21. doi: 10.1179/acb.2010.023. Acta Clin Belg. 2010. PMID: 20491361 Review.

4

18-Fluorodeoxyglucose positron emission tomography as a tool for response prediction in solid tumours.

De Maeseneer DJ, Lambert B, Surmont V, Geboes K, Rottey SW. De Maeseneer DJ, et al. Among authors: rottey sw. Acta Clin Belg. 2010 Sep-Oct;65(5):291-9. doi: 10.1179/acb.2010.065. Acta Clin Belg. 2010. PMID: 21128554

5

Cardiovascular toxicity of cancer treatment.

Combes M, Rottey S, De Backer T. Combes M, et al. Among authors: rottey s. Acta Clin Belg. 2011 Jul-Aug;66(4):260-6. doi: 10.2143/ACB.66.4.2062566. Acta Clin Belg. 2011. PMID: 21938980

6

Contemporary minimally-invasive extended pelvic lymph node dissection for prostate cancer before curative radiotherapy: prospective standardized analysis of complications.

Van Praet C, Decaestecker K, Fonteyne V, Ost P, De Visschere P, Verschuere S, Rottey S, Lumen N. Van Praet C, et al. Among authors: rottey s. Int J Urol. 2014 Nov;21(11):1138-43. doi: 10.1111/iju.12534. Epub 2014 Jun 25. Int J Urol. 2014. PMID: 24964296

7

Battling resistance mechanisms in antihormonal prostate cancer treatment: Novel agents and combinations.

De Maeseneer DJ, Van Praet C, Lumen N, Rottey S. De Maeseneer DJ, et al. Among authors: rottey s. Urol Oncol. 2015 Jul;33(7):310-21. doi: 10.1016/j.urolonc.2015.01.008. Epub 2015 Feb 21. Urol Oncol. 2015. PMID: 25708954 Review.

8

Androgen Receptor Gene Copy Number and Protein Expression in Treatment-Naïve Prostate Cancer.

Poelaert F, Kumps C, Lumen N, Verschuere S, Libbrecht L, Praet M, Rottey S, Claeys T, Ost P, Decaestecker K, De Meerleer G, Van Praet C. Poelaert F, et al. Among authors: rottey s. Urol Int. 2017;99(2):222-228. doi: 10.1159/000455158. Epub 2017 Jan 5. Urol Int. 2017. PMID: 28052297

9

Checkpoint inhibition: new treatment options in urologic cancer.

De Maeseneer DJ, Delafontaine B, Rottey S. De Maeseneer DJ, et al. Among authors: rottey s. Acta Clin Belg. 2017 Feb;72(1):24-28. doi: 10.1080/17843286.2016.1260890. Acta Clin Belg. 2017. PMID: 28151378 Review.

10

The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma: Prognostic features in the era of targeted therapies.

Claeys T, Lumen N, Kumps C, Praet M, De Meerleer G, Rottey S, Ost P, Devisschere P, Villeirs G, Fonteyne V, Decaestecker K. Claeys T, et al. Among authors: rottey s. Urol Oncol. 2017 Apr;35(4):152.e13-152.e22. doi: 10.1016/j.urolonc.2016.10.013. Epub 2017 Jan 30. Urol Oncol. 2017. PMID: 28153420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters